ArticlePathology oncology research : POR2022

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab.

Andrea Ladányi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.